The Cost Of A Cure: Patent Rights And Drug Prices
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
Record-Breaking Verdict In Patent Infringement Case
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs.
LexisNexis Practical Guidance Rolls Out Dedicated Practice Area for AI & Technology
The new generation of AI-related legal issues are inherently cross-disciplinary, implicating corporate law, intellectual property, data privacy, employment, corporate governance and regulatory compliance.